Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • Magpie101
    Junior Member
    • Jun 2016
    • 2

    Coverage Estimates from Masked/Unmasked Genome

    Hi All,

    I've carried out a mapping run with Illumina paired-end reads to a genome using BWA. From this I've calculated i) x times coverage and ii) fraction of the reference sequence covered to a depth of at least one read. My supervisor now wants me to get coverage metrics which take into account regions that have no read coverage as they are repetitive elements. In essence he just wants coverage stats for the 'mappable' region.

    So, for example, the genome I'm using is c. 2.3Gb in length and c. 50% of this is composed of repeats which reads are unlikely to map to. This will deflate the coverage estimates. So if, say, I have c. 50% of a reference sequence covered at at least 1 read depth; if I minus the 50% of the genome that are repeats then this rises to 100%. What I'm trying to figure out is if I know the annotations info for the repetitive elements can I figure this out with my existing .bam file or will I need to remap to a hard-masked genome or remove the repetitive elements somehow and then figure it out.

    I really hope this makes sense (I suspect not!).

    Thanks
    Last edited by Magpie101; 11-04-2016, 11:09 AM.
  • atcghelix
    Member
    • Jul 2013
    • 74

    #2
    The samtools "depth" command should output the coverage at only the bases that have a depth of at least 1 if that's what you want.

    But this is conceptually different than filtering out repetitive regions based on the annotations you have.

    Comment

    • dpryan
      Devon Ryan
      • Jul 2011
      • 3478

      #3
      Use GEM to determine the mappable regions and then determine coverage accordingly.

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
        by SEQadmin2


        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

        The systematic characterization of the human proteome has
        ...
        07-20-2026, 11:48 AM
      • SEQadmin2
        Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by SEQadmin2



        Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
        ...
        07-09-2026, 11:10 AM
      • SEQadmin2
        Cancer Drug Resistance: The Lingering Barrier to Rising Survival
        by SEQadmin2



        Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

        There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
        07-08-2026, 05:17 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 07-20-2026, 11:10 AM
      0 responses
      9 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-13-2026, 10:26 AM
      0 responses
      30 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-09-2026, 10:04 AM
      0 responses
      41 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-08-2026, 10:08 AM
      0 responses
      26 views
      0 reactions
      Last Post SEQadmin2  
      Working...